Literature DB >> 14585701

Improved biocompatibility of small intestinal submucosa (SIS) following conditioning by human endothelial cells.

A M Woods1, E J Rodenberg, M C Hiles, F M Pavalko.   

Abstract

Small intestinal submucosa (SIS) is a naturally occurring tissue matrix composed of extracellular matrix proteins and various growth factors. SIS is derived from the porcine jejunum and functions as a remodeling scaffold for tissue repair. While SIS has proven to be a useful biomaterial for implants in vivo, problems associated with endothelialization and thrombogenicity of SIS implants may limit its vascular utility. The goal of this study was to determine if the biological properties of SIS could be improved by growing human umbilical vein endothelial cells (HUVEC) on SIS and allowing these cells to deposit human basement membrane proteins on the porcine substrate to create what we have called "conditioned" SIS (c-SIS). Using an approach in which HUVEC were grown for 2 weeks on SIS and then removed via a technique that leaves behind an intact basement membrane, we hypothesized that the surface properties of SIS might be improved. We found that when re-seeded on c-SIS, HUVEC exhibited enhanced organization of cell junctions and had increased metabolic activity compared to cells on native SIS (n-SIS). Furthermore, HUVEC grown on c-SIS released lower amounts of the pro-inflammatory prostaglandin PGI2 into the media compared to cells grown on n-SIS. Additionally, we found that adhesion of resting or activated human platelets to c-SIS was significantly decreased compared to n-SIS suggesting that, in addition to improved cell growth characteristics, conditioning SIS with human basement membrane proteins might decrease its thrombogenic potential. In summary, conditioning of porcine SIS by human endothelial cells improves key biological properties of the material that may improve its usefulness as remodeling scaffold for tissue repair. Identification of critical modifications of SIS by human endothelial cells should help guide future efforts to develop more biocompatible vascular grafts.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2004        PMID: 14585701     DOI: 10.1016/s0142-9612(03)00552-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Autologous urothelial cells transplantation onto a prefabricated capsular stent for tissue engineered ureteral reconstruction.

Authors:  Yongde Xu; Weijun Fu; Gang Li; Jianguo Shi; Haisong Tan; Kun Hu; Fuzhai Cui; Qiuxia Lin; Xu Zhang
Journal:  J Mater Sci Mater Med       Date:  2012-03-02       Impact factor: 3.896

2.  In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications.

Authors:  Lorenzo Soletti; Alejandro Nieponice; Yi Hong; Sang-Ho Ye; John J Stankus; William R Wagner; David A Vorp
Journal:  J Biomed Mater Res A       Date:  2010-12-09       Impact factor: 4.396

3.  Improved vascular organization enhances functional integration of engineered skeletal muscle grafts.

Authors:  Jacob Koffler; Keren Kaufman-Francis; Yulia Shandalov; Shandalov Yulia; Dana Egozi; Egozi Dana; Daria Amiad Pavlov; Amiad Pavlov Daria; Amir Landesberg; Shulamit Levenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-30       Impact factor: 11.205

4.  Collagen-cellulose composite thin films that mimic soft-tissue and allow stem-cell orientation.

Authors:  Terry W J Steele; Charlotte L Huang; Evelyne Nguyen; Udi Sarig; Saranya Kumar; Effendi Widjaja; Joachim S C Loo; Marcelle Machluf; Freddy Boey; Zlata Vukadinovic; Andreas Hilfiker; Subbu S Venkatraman
Journal:  J Mater Sci Mater Med       Date:  2013-05-14       Impact factor: 3.896

5.  Reconstruction of the pulmonary artery by a novel biodegradable conduit engineered with perinatal stem cell-derived vascular smooth muscle cells enables physiological vascular growth in a large animal model of congenital heart disease.

Authors:  Mohamed T Ghorbel; Huidong Jia; Megan M Swim; Dominga Iacobazzi; Ambra Albertario; Carlo Zebele; Delphine Holopherne-Doran; Anthony Hollander; Paolo Madeddu; Massimo Caputo
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

Review 6.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

7.  Ureter regeneration-the proper scaffold has to be defined.

Authors:  Tomasz Kloskowski; Arkadiusz Jundziłł; Tomasz Kowalczyk; Maciej Nowacki; Magdalena Bodnar; Andrzej Marszałek; Marta Pokrywczyńska; Małgorzata Frontczak-Baniewicz; Tomasz A Kowalewski; Piotr Chłosta; Tomasz Drewa
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

8.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.